NEW ORLEANS, Jan. 12, 2018 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 22, 2018 to file lead plaintiff applications in a securities class action lawsuit against Triangle Capital Corporation (NYSE:TCAP), if they purchased the Company’s shares between May 7, 2014 and November 1, 2017, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
Get Help
Triangle Capital investors should visit us at https://www.claimsfiler.com/cases/view-triangle-capital-corporation-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Triangle Capital and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On November 1, 2017, Triangle revealed a decline in the fair value of its investment portfolio of nearly 7%, $8.9 million in net realized losses and $65.8 million in net unrealized depreciation for the quarter. Further, seven investments were moved to full non-accrual status and investments on non-accrual had ballooned to 13.4% and 4.7% of Triangle’s total portfolio at cost and fair value, respectively.
On this news, the price of Triangle shares plummeted nearly 21%, or $2.57 per share.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Anta Sports Expands Global Footprint With Strategic Puma Stake
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Washington Post Publisher Will Lewis Steps Down After Layoffs
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Amazon Explores AI Content Marketplace With Media Publishers
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 



